| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Cryo-Cell International, Inc.
13D/A
Amendment 1
CCEL · 228895108
|
6.8% |
7/7/2026
Event 7/2/2026
|
|||
| Camac Partners, LLC | 6.8% | ||||
| Camac Capital, LLC | 6.8% | ||||
| Camac Fund, LP | 6.8% | ||||
| Eric Shahinian | 6.8% | ||||
|
TruBridge, Inc
13G/A
Amendment 1
TBRG · 205306103
|
2.7% |
7/1/2026
Event 6/5/2025
|
|||
| Camac Partners, LLC | 2.7% | ||||
| Camac Capital, LLC | 2.7% | ||||
| Camac Fund, LP | 2.7% | ||||
| Eric Shahinian | 2.7% | ||||
|
Cryo-Cell International, Inc.
13D
CCEL · 228895108
|
5.3% |
3/25/2026
Event 3/23/2026
|
|||
| Camac Partners, LLC | 5.3% | ||||
| Camac Capital, LLC | 5.3% | ||||
| Camac Fund, LP | 5.3% | ||||
| Eric Shahinian | 5.3% | ||||
|
TruBridge, Inc.
13G
TBRG · 205306103
|
5.7% |
1/28/2026
Event 12/31/2025
|
|||
| Camac Partners, LLC | 5.7% | ||||
| Camac Capital, LLC | 5.7% | ||||
| Camac Fund, LP | 5.7% | ||||
| Eric Shahinian | 5.7% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.